Medical treatment is potentially more important than surgical treatment for the large majority of patients presenting with breast cancer. Since each patient has unique characteristics affecting both tumour aggressiveness and host defence, a generalised approach to medical treatment is no longer acceptable.
Get full access to this article
View all access options for this article.
References
1.
AhmannD. L.O'ConnellM. J.HahnR. G.BiselH. F.LeeR. A.EdmondsonJ. H. (1977). An evaluation of the early and delayed adjuvant chemotherapy in premenopausal patients with advanced breast cancer. New England Journal Medicine, 297, 356
2.
BrinkleyD.HaybittleJ. L. (1975). The curability of breast cancer. Lancet, 2, 95
3.
BrunnerK. W.SonntagR. W.AlbertoP.SennH. J.MartzG.ObrechtP.MauriceP. (1977). Combined chemo- and hormonal therapy in advanced breast cancer. Cancer (Supplement), 39, 2923
4.
CarboneP.TormeyD. C. (1977). Combination chemotherapy for advanced disease. In Breast Cancer p. 165. Edited by McGuireW. L.Edinburgh: Churchill-Livingstone
5.
CavalliF.AlbertoP.JungiF.MartzG.BrunnerK. W. (1977). Tamoxifen alone or combined with multiple drug chemotherapy in disseminated breast cancer. Tenth International Congress Chemotherapy, Abstract 510, 615
6.
EagenR. T.AhmannD. L.EdmondsonJ. H.HahnR. G.BiselH. F. (1975). Controlled evaluation of the combination of adriamycin, vincristine and methotrexate in patients with disseminated breast cancer. Cancer Chemotherapy Reports, 6, 339
7.
FreiE. (1977). Rationale for combined therapy. Cancer (Supplement), 40, 569
8.
GuttermanJ. U.CardenasJ. O.BlumenscheinG. R.HortobaguiG.LivingstonR. B.MavligttG. M.FreireichE. J.GottliebJ. A.HershE. M. (1976). Chemoimmunotherapy of disseminated breast cancer. Prolongation of remission and survival. British Medical Journal, 2, 1222
9.
HeusonJ. C. (1976). Current overview of EORTC clinical trials with tamoxifen. Cancer Treatment Reports, 60, 1463
10.
IsraelL. (1976). Immunochemotherapy with C. Parvum in disseminated cancer. Annals of New York Academy Science, 277, 241
11.
KiangD. T.KennedyB. J. (1975). The effect of short term cyclophosphamide on estrogen therapy in breast cancer. Proceedings American Association for Cancer Research, 16, 107
12.
McGuireW. L. (1975). Current status of estrogen receptors in human breast cancer. Cancer, 36, 638
13.
RamirezG.StrawitzJ. G.WilsonW. L.CornellG. N.MaddenR. E. (1975). Multiple drug therapy in disseminated breast carcinoma. A randomised study. Proceedings American Association for Cancer Research, 6, 33
14.
RawboneR. G.BagshaweG. (1972). Anabolic steroids and bone marrow toxicity during therapy with methotrexate. British Journal Cancer, 26, 395
15.
RojasA.FeiersteinJ.MickiewiczE.GleitH. (1976). Levamisole in advanced human breast cancer. Lancet, 1, 211
16.
SantenR. J.SamolijkE.LiptonA.HarveyH.RubyE. B.WellsS. A.KendallJ. (1977). Kinetic hormonal and clinical studies with aminoglutethimidein breast cancer. Cancer (Supplement), 39, 2949
17.
SkipperH. E. (1971). The kinetics of mammary tumour cell growth and implications for therapy. Cancer, 28, 1479
18.
StollB. A. (1971a) Palliation by hormone administration. In Breast Cancer Management -Early and Late, p. 133. Edited by StollB. A.London: Heineman Medical
19.
StollB. A.(1977b). Selective mechanisms in hormonal therapy, InSecondary Spread in Breast Cancer p.169. Edited by StollB. A.London: Heineman Medical
20.
TagnonH. J. (1977). Anti-estrogens in the treatment of breast cancer. Cancer (Supplement), 39, 2959
21.
TaylorS. G.PocockS. J.ShniderB. J.ColskyJ.HallT. C. I. (1975). Clinical studies of fluorouracil and premarin in the treatment of breast cancer. Medical and Pediatric Oncology, 1, 113
